Healthcare
Singapore medical inflation to hit 16.9% in 2026
Singapore medical inflation to hit 16.9% in 2026
Key drivers of rising healthcare costs in Singapore include an ageing population and a higher incidence.
iX Biopharma accelerates WaferiX portfolio commercialisation with Orion Labs deal
iX will commercialise its WaferiX drug delivery using Orion’s healthcare network in the county.
SGH, NUS research reveals how magnets can help patients with type 2 diabetes
The treatment mimics the effects of exercise without the physical strains.
First REIT renews short-term lease for Siloam Hospitals Lippo Cikarang
Extension sustains rental income as trust reviews Indonesian healthcare portfolio.
MEURAKI to double partners, expand gamified wellness platform
It is raising money from its first seed funding round.
Q&M Dental eyes Thailand expansion with local dental chain deal
The deal values the Thai company at $77.8m.
Cordlife granted extension to appeal license suspension
The company stopped collection of cord blood units before suspension period
Singapore, Australia expand cooperation under CSP 2.0
The partnership outlines a ten-year framework across five key pillars.
IHH Healthcare launches ‘Global Incubator Programme’ for startups
The group will work with selected participants in three-month development cycles.
Cordlife assures continuity of operations amidst possible licence suspension
Unaudited 1H2025 results support the company’s outlook.
HSA, SMF unveil MedTech ecosystem to enhance regulatory readiness
SME Centre@SMF will offer services such as regulatory consultations, horizon scanning workshops, and whitepapers.
Gov’t to stop use of Child Dev’t Accounts at optical shops, retail pharmacies
This decision followed audit findings that showed a higher risk of misuse at these outlets.
Cordlife to assess ‘going concern’ viability amidst potential suspension
The company said it cannot determine the financial impact for FY2025.
Cordlife faces one-year suspension for cord blood banking service
The suspension requires the company to ensure the safety and quality of its cord blood units.
Vicplas International posts $2.4m net loss in FY2025
The group’s loss per share was $0.0046.
Ang Hao Yao raises AsiaMedic stake to 5.046%
Ang now holds 57 million voting shares in the company.
AJJ Medtech awarded $2m supply contract
It is expected to provide recurring revenue whilst deepening AJJ’s institutional footprint across the country.
Read Here
Advertise
Sign Up
Commentary
Singapore’s family offices: Time to professionalise or risk falling behind
Liquidity crucial to stock market reform